Moderna said on Friday that the U.S. FDA paused a late-stage trial of its experimental norovirus vaccine after a case of a ...
The FDA is mired in uncertainty with some staffers losing their jobs over the weekend and more potentially to come, vaccines ...
Moderna’s norovirus vaccine trial placed on FDA hold over reported case of Guillain-Barré syndrome
A trial of Moderna’s norovirus vaccine in the U.S. has been put on hold by the FDA over a reported case of neurological ...
EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...
Zacks.com on MSN1d
Should You Buy, Hold or Sell Moderna Stock Post Q4 Earnings Release?Given the uncertainty around its revenue growth, we advise short-term investors to remain cautious when investing in MRNA ...
Moderna (MRNA) said that the two-season Phase 3 study evaluating the efficacy, safety and immunogenicity of Moderna’s trivalent vaccine against ...
The U.S. FDA paused Moderna's norovirus vaccine trial due to a rare side effect. U.S. Health Secretary Robert F. Kennedy Jr's initiatives may face budget cuts. Wyoming reports a human bird flu case.
Recent health news highlights US FDA's hold on Moderna's norovirus vaccine trial due to a side-effect case, Robert F. Kennedy ...
(Reuters) -Moderna said on Friday that the U.S. FDA paused a late-stage trial of its experimental norovirus vaccine after a case of a rare neurological side effect was reported. The trial of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback